Interestingly, we found that ESRP2 suppressed the expression of TAK1_ΔE12, the fetal and oncogenic isoform of TAK1, resulting in impaired proliferation and migration of HCC cells. Here, ESRP2 is linked to hepatocellular carcinoma.